ALECIA EADS: Open Payments
NPI 1912485293 · GATESVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 28 payments from 9 companies in 2025. Trend: 2023 $491 · 2024 $509 · 2025 $484
Food & beverage: $484
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $173 |
| Novo Nordisk Inc | 5 | $85 |
| PFIZER INC. | 4 | $75 |
| Sumitomo Pharma America, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, Wegovy, GEMTESA, NURTEC ODT, PREVNAR 20, TRELEGY ELLIPTA, REXULTI.
Industry payments across TX — which companies pay providers there.
